NeoCore Technology Co., Ltd. engages in the research, development, manufacture, and sale of biochips. It develops and provides food safety examination system, human diagnosis arrays system, agriculture examination system, food examination arrays system and laboratory instruments and design system. The company's products include biochips, fast nucleic acid hybridization devices, nucleic acid extraction kits, and polymerase chain reaction kits. DR. Chip Biotechnology was founded on October 22, 1998 and is headquartered in Taichung, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company